Cipla Limited FII & DII Activity

FII Net (₹ Cr)

+871.83Buy 16,834.53Sell 15,962.7

DII Net (₹ Cr)

+643.35Buy 17,240.9Sell 16,597.55

FII F&O Net (contracts)

+643395Index + stock futures

5-Day Flow Trend

Date	FII Net (₹ Cr)	DII Net (₹ Cr)
2026-10-28	+871.83	+643.35
2026-10-27	−1462.49	+2609.57
2026-10-26	−1462.49	+2609.57
2026-10-23	+887.65	+3235.36
2026-10-22	−3458.70	+2891.32

AI AnalysisGenerated daily after market close · AI-powered

Today's Institutional Flow

FII cash buying in the market totals ₹871.83 crore, while DII cash buying adds another ₹643.35 crore, indicating a combined net cash inflow of roughly ₹1,515 crore today. FII activity dominates the equity side, whereas DII participation remains robust but comparatively smaller. No block or bulk trades are reported for Cipla Limited, so the institutional interest is reflected solely in aggregate market‑wide cash numbers.

Trend vs 5‑Day Average

The day’s FII cash flow of +₹871.83 crore contrasts sharply with the five‑day average net outflow of ₹‑894.74 crore, signaling a reversal from the recent selling pressure. Conversely, DII cash buying of +₹643.35 crore sits below the five‑day average inflow of ₹2,592.03 crore, suggesting a modest slowdown in domestic institutional buying relative to the prior week.

F&O Positioning Data

Foreign Institutional Investors hold net F&O exposure of +₹643,395 crore, underscoring a substantial speculative or hedging stance across derivatives. Their index‑futures positioning shows a long‑to‑short ratio of 1.2, indicating a modest net bullish tilt in the broader market futures book.

Healthcare Sector Flow

The healthcare sector, of which Cipla is a key component, continues to attract modest net buying from DII while FII flows remain neutral, reflecting a steady but unspectacular accumulation trend in recent weeks.

Market-wide FII/DII data — same for all F&O stocks. Date: 2026-10-28

Same Sector

ALKEMAlkem Laboratories LimitedNeutral APOLLOHOSPApollo Hospitals Enterprise LimitedNeutral AUROPHARMAAurobindo Pharma LimitedNeutral BIOCONBiocon LimitedNeutral DIVISLABDivi's Laboratories LimitedNeutral

Frequently Asked Questions

What is FII net buying/selling in Cipla Limited today?

FII (Foreign Institutional Investor) net flow in the Indian cash market today is ₹871.83 Cr (net buying) as of 2026-10-28. This market-wide figure applies to all F&O stocks including Cipla Limited.

What is DII activity in Cipla Limited today?

DII (Domestic Institutional Investors — mutual funds, insurance companies) net flow is ₹643.35 Cr (net buying) today. DIIs often act as a counterbalancing force to FII flows — on days when FIIs sell, DIIs typically provide support.

What is FII F&O net for Cipla Limited today?

FII net F&O position (index + stock futures combined) is +6,43,395 contracts as of the latest participant OI data. A positive number means FIIs are net long in futures; negative means net short.

Were there any block deals in Cipla Limited?

Block deal data for Cipla Limited is tracked daily from NSE's block deal window. On days with activity, the deal value in ₹ Crore is shown on this page.

How does FII/DII data affect Cipla Limited stock price?

FII and DII flows are market-wide data — all F&O stocks including Cipla Limited are influenced. When FIIs buy heavily (positive net), it typically supports the broader market. When FII F&O net is strongly positive (long futures), it signals institutional conviction in an uptrend. Combined with Cipla Limited's individual OI buildup type, this provides a directional framework.